🔗 Visit the ClinicalTrials.gov page for NCT01538719
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. | Nat Rev Drug Discov | 2012 | 4.40 |
| 2 | Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. | Cancer Growth Metastasis | 2015 | 0.90 |
| 3 | Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. | Mediators Inflamm | 2015 | 0.89 |
| 4 | Targeted therapies for systemic sclerosis. | Nat Rev Rheumatol | 2013 | 0.82 |
| 5 | Current perspectives on the immunopathogenesis of systemic sclerosis. | Immunotargets Ther | 2016 | 0.79 |
| 6 | Animal models of systemic sclerosis: their utility and limitations. | Open Access Rheumatol | 2014 | 0.75 |
| 7 | Treatment of systemic sclerosis: is there any hope for the future? | RMD Open | 2016 | 0.75 |